Carl Zeiss Meditec AG

PNK: CZMWF · Real-Time Price · USD
64.16
-4.42 (-6.45%)
At close: May 07, 2025, 10:22 AM

Carl Zeiss Meditec Income Statement

Financials in EUR. Fiscal year is October - September.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
2.56B 2.54B 2.54B 2.54B 2.09B 2.09B 2.08B 2.02B 1.96B 1.9B 1.78B 1.73B 1.69B 1.65B 1.57B 1.39B 1.33B
Cost of Revenue
993.35M 977.45M 927.39M 900.67M 893.13M 883.53M 844.73M 846.13M 810.74M 775.24M 755.37M 704.28M 695.33M 679.53M 656.2M 602.04M 588.13M
Gross Profit
1.56B 1.56B 1.61B 1.64B 1.2B 1.21B 1.23B 1.18B 1.15B 1.13B 1.03B 1.03B 992.74M 967.24M 909.55M 785.84M 746.55M
Operating Income
222.44M 253.04M 340.81M 422.03M 411.29M 428.59M 453.26M 408.12M 432.9M 413.1M 349.23M 377.19M 336.09M 348.39M 363.78M 254.31M 216.32M
Interest Income
15.68M 23.28M 31.45M 37.11M 34.86M 29.96M 24.16M 17.47M 17.37M 13.27M 6.98M 6.27M 1.33M 1.53M 1.52M 1.54M 1.49M
Pretax Income
206.22M 240.82M 287.82M 370.84M 394.22M 412.52M 437.04M 393.03M 422.42M 403.52M 339.58M 367.52M 326.51M 339.01M 338.68M 228.31M 189.45M
Net Income
157.03M 178.73M 203.2M 261.22M 276.75M 290.35M 307.86M 278.24M 306.97M 293.87M 245.24M 264.29M 227.87M 236.27M 235.38M 159.08M 129.87M
Selling & General & Admin
596.69M 569.19M 534.84M 504.5M 509.13M 504.03M 498.13M 484.76M 456.29M 438.09M 416.31M 391.51M 379.75M 363.95M 336.73M 325.6M 333.65M
Research & Development
332.81M 343.11M 352.1M 358.2M 356.11M 349.31M 342.8M 326.38M 311.83M 291.33M 269.73M 250.69M 238.4M 232.1M 226.74M 224.92M 221.14M
Other Expenses
-841.02M -838.92M -839M -839M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.56B 1.55B 1.52B 1.5B 869.55M 857.65M 841.93M 812.35M 769.41M 730.71M 686.29M 642.28M 618.15M 593.65M 561.12M 548.12M 552.4M
Interest Expense
32.44M 29.44M 23.17M 18.38M 17.07M 16.07M 16.21M 15.09M 10.48M 9.58M 9.65M 9.68M 9.58M 9.38M 25.1M 26M 26.87M
Selling & Marketing Expenses
477.45M 458.15M 433.03M 421.05M 423.76M 420.26M 412.56M 399.14M 374.81M 360.21M 346.47M 326.55M 318.12M 303.22M 280.63M 270.08M 278.16M
Cost & Expenses
2.33B 2.3B 2.23B 2.18B 1.76B 1.74B 1.69B 1.66B 1.58B 1.51B 1.44B 1.35B 1.31B 1.27B 1.22B 1.15B 1.14B
Income Tax Expense
47.95M 60.74M 84.49M 108.89M 116.08M 120.58M 127.41M 113.44M 114.02M 107.61M 92.67M 101.4M 97.32M 101.52M 101.19M 68.46M 58.27M
Shares Outstanding (Basic)
87.22M 89.74M 89.74M 89.38M 89.05M 89.44M 89.38M 89.44M 89.47M 89.44M 89.33M 89.44M 90.24M 89.44M 88.28M 89.03M 89.04M
Shares Outstanding (Diluted)
87.22M 89.74M 89.74M 89.38M 89.05M 89.44M 89.38M 89.44M 89.47M 89.72M 89.33M 89.83M 90.24M 89.82M 88.28M 89.03M 89.04M
EPS (Basic)
2.18 2.42 3.72 4.37 4.69 4.84 4.01 3.68 3.43 3.28 3.65 3.87 3.47 3.57 2.70 1.84 1.51
EPS (Diluted)
1.76 2.00 3.30 3.95 4.69 4.84 4.00 3.67 3.42 3.27 3.65 3.87 3.47 3.57 2.70 1.84 1.51
EBITDA
238.66M 270.26M 310.99M 389.22M 411.29M 428.59M 453.26M 408.12M 432.9M 413.1M 349.23M 377.19M 358.98M 371.28M 386.67M 282.46M 237.86M
EBIT
238.66M 270.26M 310.99M 389.22M 411.29M 428.59M 453.26M 408.12M 432.9M 413.1M 349.23M 377.19M 336.09M 348.39M 363.78M 254.31M 216.32M
Depreciation & Amortization
-29.82M -24.4M 12.41M 14.57M 84.63M 84.37M 84.28M 83.77M 79.56M 79.05M 73.99M 75.12M 72M 73.14M 74.07M 73.27M 71.19M